Age-Related Macular Degeneration (AMD)

A medical definition of vision impairment is a sine qua non that prohibits 20/20 vision in one or both eyes (Bowman, Bowman, Dutton & Royal National Institute for the Blind, 2001; Vision Australia, 2015; Webster & Roe, 1998). Examples of vision impairment include, cataracts, which has the lens inside the eye increasingly cloudy; albinism, which is passed down genetically affecting clear vision and causes sensitivity to bright light; optic nerve damage, which affects field of vision as those nerves controlling vision are disrupted; macular degeneration, where parts of the retina that control colour and fine details are affected; retinitis pigmentosa, which is an ongoing reduction of the field of vision available and nystagmus, where the eye flickers involuntary (Bowman, Bowman, Dutton & Royal National Institute for the Blind, 2001; American Foundation for the Blind, 2015; Vision Australia, 2015 ; Baton Rouge Regional Eye Bank, 2015). John suffers from retinitis

Macular Degeneration is a disease of the eye that gradually causes loss of a person’s central vision. Approximately 1.75 million Americans suffer from vision loss associated with the disease (All About Vision 1). The leading cause of blindness in people over the age of 60, Macular Degeneration, exists in two types (National Eye Institute 1). Both the wet and dry versions of the disease have similarities in risk factors, but differ in symptoms and treatments.

The research topic I will be introducing is Age-Related Macular Degeneration. This has been classified as a degenerative disorder that distresses the macula in one’s eye. AMD is unfortunately a common illness that individuals over 65 suffer from and that is a central cause vision loss. AMD doesn’t have a set disease pathway, in some individuals it advances slowly so that loss of vision does not arise for a long time. The disease can also advance much quicker and may lead to lack of vision in either or both eyes. The disease begins a blurry area near the center of one’s vision which grows larger and larger possibly causing a blank space in the eye (Boyd, 2013). Research is being done on AMD because it is a prevalent illness and has extreme consequences.

People with M.S. may have many symptoms. Impaired vision is one in which the optic nerve becomes

Retinitis Pigmentosa (RP) is one of such currently untreatable causes of blindness. RP, along with Age Related Macular Degeneration (AMD) are amongst the more frequent causes of blindness in the developed world (Greenwald 2009), while RP itself is the leading cause of inherited blindness (Palanker 2004).

Visual impairment is a state wherein an individual experiences difficulty in seeing or not being able to see anything physical presented to them. According to Mandal, MD (2013) It is a state where a visually impaired person’s eyesight cannot be corrected back to a “normal level”. Visual impairment is often associated with old age. In Europe, an estimated 15.5 million people have visual impairment and in seven countries in Europe, about 50% of blindness is caused by age-related macular degeneration. (Dibb,

Age-related macular degeneration (AMD) is the leading cause of blindness for people 60 years of age and older in the developed world. Vision loss is caused by the destruction of the cone photoreceptors, located in the macula, that are responsible for color/central vision. The underlying cause of AMD is the loss of the monolayer of pigmented epithelial cells located just below the photoreceptors, known as the retinal pigmentum epithelium (RPE). The main role of the RPE is to maintain the function of the photoreceptor layer by secreting nutrients, absorbing stray light, and recycling debris used during the visual cycle. As a person ages the efficiency of the RPE layer is diminished causing a build up of toxic by-products. These toxic build-ups, known as drusens, result in the separation and death of the photoreceptor and RPE layers. AMD is speculated to result from as many as 20 different genetic mutations and as a result there is no known cure for the disease (CITE), but recent advances in stem cell therapy is a hopeful step in the right direction.

The study shows that the patients with AMD have decreased function psychologically along with functionally. The data for the research was chosen at random “The participants were divided into two groups: participants diagnosed with AMD, and participants without reported ocular diseases” (Pg 376). The people chosen for this study were over the age of 55 with evidence of AMD. In the study it stated they used the “nine depression items from the Goldberg Anxiety and Depression Scale” (Pg 376) . A patient having AMD had a 36% chance of having depressive symptoms where the controls used in the study had a 30% chance of having depressive symptoms (Pg 377). It is also shown that over half of the people with AMD have depressive symptoms. It is believed that these people have depressive symptoms due to having a decreased quality of life. Lastly, it is shown that people with AMD do not compare to people of similar age when it comes to socializing and functioning.

Age-related macular degeneration also known as AMD is a disease leading to severe vision and legal blindness in the elderly population. I will address the health condition description and the disability and functional implications who suffer from this disease.

Age related macular degeneration is a loss of function of the macula, it is more commonly known as AMD. AMD is the most common cause for vision loss in adult s over the age of 55. The macula, located in the central part of the eye, is what is being damaged. This part of the eye is what enables us to see substances that are directly in front of the field of vision.

Macular Degeneration is a disease that affects the retina of the eye. The retina is a layer in the back of the eye that helps us to see. It is also the lining of the eye that helps us respond to light. However, when having macular degeneration there are major changes in a person's central vision. The disease causes central images to appear blurred and then dark spots may begin to appear that get larger and larger. It may also be very hard to see straight lines as Macular Degeneration may cause them to be curved. When having this disease color may appear to be darker and less vivid than normal.

Glaucoma is several conditions of the eye that damage the optic nerve, which is vital to perfect vision. This damage is caused due to an abnormally high pressure in your eye. Glaucoma is one of the leading causes of blindness in the United States. It can happen at any age but is most common in older adults. If you lose your vision due to glaucoma, it is not possible to gain it back. It is important to get regular eye appointments because if glaucoma is caught early, the loss of vision can be slowed or prevented. There are two types of glaucoma. Open-angle glaucoma and acute angle-closure glaucoma. The symptoms for these two are very different. Open-angle glaucoma symptoms include patchy blind spots in your central or side vision,

Stated by Web MD, for most people, there are usually few or no symptoms of glaucoma. The first sign of glaucoma is often the loss of peripheral or side vision, which can go unnoticed until late in the disease. This is why glaucoma is often called the "sneak thief of vision." Symptoms to look out for include, seeing halos around lights, vison loss, redness in the eye, nausea, pain in the eye, and narrowing of vison otherwise known as tunnel vison.

     Macular Degeneration is a problem in the part of the eye that controls your sharpest central vision. It is a group of diseases that result in a loss of detailed vision. The brain will not just leave the spot empty, so it learns to fill it in with spotty macular cell damage. People most of the time don't tell their doctors (opthalmologists) about it until it is well in advance.

The disease has a predictable progression, advancing from the initial non-proliferative DR (NPDR), which can be asymptomatic, to the end-stage proliferative type (PDR). The rate and onset of progression is variable, as it is affected by blood pressure and blood sugar levels1. The features of NPDR include: microaneurysms, haemorrhages and exudation. Additionally PDR involves neovascularisation, resulting in vision loss. Diabetic macular oedema (DME) is also a cause of vision loss. Thickening of the retina at the macula can occur at any stage of DR, leading to blurred or distorted central vision1.